AK5 rs10493596: Chronotype and Sleep Patterns
The single nucleotide polymorphism rs10493596 is a common non-coding variant situated upstream of the adenylate kinase 5 (AK5) gene. Large-scale genome-wide association studies have identified this locus as being moderately associated with natural circadian preference, specifically a tendency toward morningness. Carrying the minor allele has also been correlated with a lower reported likelihood of experiencing co-occurring sleep initiation and maintenance difficulties.
What each genotype means
Typical morningness preference
This genotype is associated with a standard preference for morning activity. Research indicates that individuals with this genetic profile are less likely to report symptoms of sleep onset or terminal insomnia compared to those carrying the alternative allele.
This is the most common genotype in European populations, carried by approximately 65-70% of individuals.
Increased morningness tendency
Carrying one copy of the T allele is linked to a stronger preference for morning activity and a reduced likelihood of experiencing co-occurring sleep onset and terminal insomnia. This association is based on statistical trends in large population studies and does not determine individual sleep behavior.
This genotype is found in roughly 25-30% of individuals of European ancestry.
Stronger morningness preference
This genotype is associated with the highest statistical likelihood of morningness preference and a reduced risk of specific insomnia symptoms. These findings reflect population-level associations and should not be used to predict personal sleep quality or diagnose sleep disorders.
This is the least common genotype, appearing in approximately 3-5% of individuals of European ancestry.
Genomic Location and Variant Characteristics
The genetic marker rs10493596 represents an intergenic single nucleotide polymorphism situated on human chromosome 1. It is positioned approximately 21 kilobases upstream of the promoter region of the adenylate kinase 5 (AK5) gene. Because it falls within a non-coding genomic territory, the variant does not alter the primary amino acid sequence of any peptide. Instead, variants in this regulatory vicinity frequently exert their phenotypic influences by altering local chromatin structure, modifying transcription factor binding affinity, or modulating the transcriptional expression levels of downstream target genes. While rs10493596 is the primary sentinel marker identified across multiple sleep cohorts, researchers often evaluate it in tandem with neighboring variants in strong linkage disequilibrium across the 1p31 chromosomal region.
Biological Role of the AK5 Gene
The AK5 gene encodes adenylate kinase 5, an enzyme that belongs to an evolutionarily conserved family of nucleoside monophosphate kinases. This enzyme is predominantly expressed within brain tissue, particularly within cortical regions and the hippocampus. Adenylate kinases are critical regulators of cellular bioenergetics; they catalyze the reversible transfer of phosphate between adenosine triphosphate (ATP), adenosine diphosphate (ADP), and adenosine monophosphate (AMP). Through this biochemical activity, AK5 helps maintain local adenine nucleotide homeostasis in neural circuits. Proper cellular energy balance and adenine nucleotide signaling—especially involving purinergic signaling molecules like adenosine—are known to serve as fundamental molecular substrates underlying homeostatic sleep pressure and the broader mammalian circadian system.
Scientific Evidence and Trait Associations
The initial genome-wide discovery linking rs10493596 to chronotype emerged from massive population-scale analyses evaluating self-reported sleep parameters in hundreds of thousands of adults. In published cohorts from biobanks and consumer cohorts, rs10493596 met stringent thresholds for genome-wide significance with morningness preference. Beyond establishing an earlier natural wake-and-sleep cycle, statistical modeling of insomnia sub-phenotypes has associated the minor allele with a modest reduction in the risk of experiencing concurrent sleep onset and terminal waking insomnia. The overall evidence strength for this association is characterized as moderate: the statistical signal is robust and replicable across large datasets, though individual effect sizes remain very modest, typical of complex polygenic behavioral traits.
Ancestry and Population Distribution
The frequency of rs10493596 alleles varies noticeably across diverse geographic ancestries. In cohorts of European descent, where the vast majority of sleep GWAS discovery efforts have historically been conducted, the minor allele demonstrates an estimated frequency of approximately 0.15 to 0.20. In non-European continental populations, such as East Asian, African, and South Asian groups, allele distributions and surrounding linkage disequilibrium architectures can differ substantially. As a result, researchers exercise caution when extrapolating the precise statistical magnitude of this variant across non-European ancestries until dedicated, large-scale sleep genetics cohorts with broader ancestral representation complete equivalent functional replication studies.
Translating Genetic Findings into Perspective
Understanding your rs10493596 genotype offers fascinating educational insight into your biological chronotype tendencies, but it is not a diagnostic tool for clinical sleep disorders. Chronotype and sleep architecture are polygenic, shaped by thousands of common genetic loci acting in combination with powerful environmental factors. Exposure to morning sunlight, consistent bedtime schedules, screen habits, caffeine consumption, and stress typically exert a stronger everyday effect on sleep latency and quality than any individual SNP. Genetic results should never replace medical advice; anyone experiencing chronic sleep disruption, severe insomnia, or persistent daytime fatigue should consult a physician or sleep specialist rather than rely on genetic markers.
How common is this variant?
The minor allele of rs10493596 maintains an estimated frequency between 0.15 and 0.20 in populations of European ancestry, meaning roughly 25% to 35% of individuals carry at least one copy. Data across other global ancestries remain more limited in sleep association studies, reflecting differences in local linkage patterns.
Frequently asked questions
Does having the rs10493596 morningness variant mean I am naturally an early bird?
Not necessarily. While rs10493596 is statistically linked to morningness, it only contributes a very small amount toward your total biological chronotype. Chronotype is shaped by hundreds of genetic variants alongside daily light exposure, age, and personal schedule.
Can this genetic variant protect me from developing insomnia?
No single genetic variant can prevent clinical insomnia. Studies note a slight statistical reduction in combined sleep onset and terminal waking symptoms among carriers of the minor allele, but lifestyle factors, stress, and medical conditions have a far greater impact on sleep health.
What does the AK5 gene do in the body?
The AK5 gene encodes adenylate kinase 5, an enzyme primarily found in brain tissue. It helps maintain the balance of energetic molecules like ATP, ADP, and AMP in neurons, which indirectly influences sleep homeostasis and neural signaling.
Should I change my sleep medication or routine based on my rs10493596 genotype?
No. Genetic variations found in association studies like this are educational and do not guide clinical treatments or drug choices. You should never alter prescribed sleep aids, medications, or therapy plans without consulting your doctor or pharmacist.
Sources & further reading
Educational information only, last refreshed 9/8/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10493596?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29